| Year |
Citation |
Score |
| 2023 |
Patil S, Vijayanand S, Menon I, Gomes KB, Kale A, Bagwe P, Yacoub S, Uddin MN, D'Souza MJ. Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice. Pharmaceuticals (Basel, Switzerland). 16. PMID 37631046 DOI: 10.3390/ph16081131 |
0.526 |
|
| 2023 |
Braz Gomes K, Vijayanand S, Bagwe P, Menon I, Kale A, Patil S, Kang SM, Uddin MN, D'Souza MJ. Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles. International Journal of Molecular Sciences. 24. PMID 37445784 DOI: 10.3390/ijms241310612 |
0.557 |
|
| 2023 |
Kale A, Joshi D, Menon I, Bagwe P, Patil S, Vijayanand S, Braz Gomes K, Uddin MN, D'Souza MJ. Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs) Elicit a Significant Immune Response in a Pre-Clinical Murine Model. Vaccines. 11. PMID 36992167 DOI: 10.3390/vaccines11030583 |
0.533 |
|
| 2023 |
Vijayanand S, Patil S, Menon I, Braz Gomes K, Kale A, Bagwe P, Uddin MN, Zughaier SM, D'Souza MJ. An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice. Pharmaceutics. 15. PMID 36986756 DOI: 10.3390/pharmaceutics15030895 |
0.532 |
|
| 2023 |
Menon I, Kang SM, Braz Gomes K, Uddin MN, D'Souza M. Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response. Vaccine. 41: 1209-1222. PMID 36631361 DOI: 10.1016/j.vaccine.2023.01.002 |
0.531 |
|
| 2023 |
Patil S, Vijayanand S, Joshi D, Menon I, Braz Gomes K, Kale A, Bagwe P, Yacoub S, Uddin MN, D'Souza MJ. Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model. International Journal of Pharmaceutics. 632: 122583. PMID 36610521 DOI: 10.1016/j.ijpharm.2023.122583 |
0.547 |
|
| 2022 |
Vijayanand S, Patil S, Joshi D, Menon I, Braz Gomes K, Kale A, Bagwe P, Yacoub S, Uddin MN, D'Souza MJ. Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus. Vaccines. 10. PMID 36146568 DOI: 10.3390/vaccines10091491 |
0.542 |
|
| 2022 |
Vo TP, Panicker G, Braz-Gomes K, Parenky AC, Rajbhandari I, Rajeevan MS, Unger ER, D'Souza MJ, Uddin MN. Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route. Pharmaceuticals (Basel, Switzerland). 15. PMID 36145349 DOI: 10.3390/ph15091128 |
0.526 |
|
| 2021 |
Joshi D, Gala RP, Uddin MN, D'Souza MJ. Novel Ablative Laser Mediated Transdermal Immunization for Microparticulate Measles Vaccine. International Journal of Pharmaceutics. 120882. PMID 34298102 DOI: 10.1016/j.ijpharm.2021.120882 |
0.545 |
|
| 2021 |
Joshi D, Chbib C, Uddin MN, D'Souza MJ. Evaluation of Microparticulate (S)-4,5-Dihydroxy-2,3-pentanedione (DPD) as a Potential Vaccine Adjuvant. The Aaps Journal. 23: 84. PMID 34131810 DOI: 10.1208/s12248-021-00617-6 |
0.539 |
|
| 2021 |
Menon I, Bagwe P, Gomes KB, Bajaj L, Gala R, Uddin MN, D'Souza MJ, Zughaier SM. Microneedles: A New Generation Vaccine Delivery System. Micromachines. 12. PMID 33919925 DOI: 10.3390/mi12040435 |
0.526 |
|
| 2020 |
Bagwe P, Bajaj L, Gala R, Zughaier SM, Uddin MN, D'Souza MJ. Meningococcal Vaccines: Challenges and Prospects. Vaccines. 8. PMID 33291728 DOI: 10.3390/vaccines8040738 |
0.485 |
|
| 2020 |
Vijayanand S, Gomes KB, Gala RP, Uddin MN, D'Souza MJ. Exploring the Potential of T-Cells for a Universal Influenza Vaccine. Vaccines. 8. PMID 33050614 DOI: 10.3390/vaccines8040598 |
0.465 |
|
| 2020 |
Bansal A, Gamal W, Menon IJ, Olson V, Wu X, D'Souza MJ. Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105560. PMID 32949750 DOI: 10.1016/J.Ejps.2020.105560 |
0.311 |
|
| 2019 |
Parenky AC, Akalkotkar A, Mulla NS, D'Souza MJ. Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine. Vaccine. PMID 31477437 DOI: 10.1016/J.Vaccine.2019.08.033 |
0.327 |
|
| 2019 |
Bansal A, Gamal W, Wu X, Yang Y, Olson V, D'Souza MJ. Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception. Nanomedicine : Nanotechnology, Biology, and Medicine. 102049. PMID 31279062 DOI: 10.1016/J.Nano.2019.102049 |
0.311 |
|
| 2018 |
Gala RP, Zaman RU, D'Souza MJ, Zughaier SM. Novel Whole-Cell Inactivated Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization. Vaccines. 6. PMID 30181504 DOI: 10.3390/Vaccines6030060 |
0.38 |
|
| 2018 |
Bansal A, Wu X, Olson V, D'Souza MJ. Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel. International Journal of Pharmaceutics. PMID 29746999 DOI: 10.1016/J.Ijpharm.2018.05.018 |
0.38 |
|
| 2018 |
Allotey-Babington GL, Nettey H, D’Sa S, Braz Gomes K, D'Souza MJ. Cancer chemotherapy: Effect of poloxamer modified nanoparticles on cellular function Journal of Drug Delivery Science and Technology. 47: 181-192. DOI: 10.1016/J.Jddst.2018.06.012 |
0.72 |
|
| 2016 |
Gala RP, Popescu C, Knipp GT, McCain RR, Ubale RV, Addo R, Bhowmik T, Kulczar CD, D'Souza MJ. Physicochemical and Preclinical Evaluation of a Novel Buccal Measles Vaccine. Aaps Pharmscitech. PMID 27357420 DOI: 10.1208/S12249-016-0566-3 |
0.788 |
|
| 2016 |
Tawde SA, Chablani L, Akalkotkar A, D'Souza MJ. Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 235: 147-154. PMID 27238440 DOI: 10.1016/J.Jconrel.2016.05.058 |
0.346 |
|
| 2016 |
Gala RP, D'Souza M, Zughaier SM. Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular oolysaccharide-based vaccine. Vaccine. PMID 27177946 DOI: 10.1016/J.Vaccine.2016.05.010 |
0.34 |
|
| 2016 |
Cotta KI, Addo RT, D'Souza MJ. Evaluation of the Intestinal Colonizing Potential and Immunomodulating Capacity of Lactobacilli Microspheres. Journal of Pharmaceutical Sciences. PMID 27044945 DOI: 10.1016/J.Xphs.2016.02.016 |
0.798 |
|
| 2015 |
Patel JM, Vartabedian VF, Bozeman EN, Caoyonan BE, Srivatsan S, Pack CD, Dey P, D'Souza MJ, Yang L, Selvaraj P. Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth. Biomaterials. 74: 231-244. PMID 26461116 DOI: 10.1016/J.Biomaterials.2015.09.031 |
0.338 |
|
| 2015 |
Addo RT, Yeboah KG, Siwale RC, Siddig A, Jones A, Ubale RV, Akande J, Nettey H, Patel NJ, Addo E, D'Souza MJ. Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery. Journal of Pharmaceutical Sciences. 104: 1677-90. PMID 25652269 DOI: 10.1002/Jps.24380 |
0.792 |
|
| 2014 |
D'Souza B, Bhowmik T, Uddin MN, Oettinger C, D'Souza M. Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery. Drug Development and Industrial Pharmacy. 1-6. PMID 25156483 DOI: 10.3109/03639045.2014.947507 |
0.728 |
|
| 2014 |
Patel N, Addo RT, Ubale R, Uddin MN, D'Souza M, Jobe L. The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. Journal of Drug Targeting. 22: 796-804. PMID 24892743 DOI: 10.3109/1061186X.2014.921927 |
0.767 |
|
| 2013 |
Enriquez GG, Rizvi SA, D'Souza MJ, Do DP. Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. International Journal of Nanomedicine. 8: 1393-402. PMID 23630421 DOI: 10.2147/Ijn.S43479 |
0.739 |
|
| 2013 |
Uddin MN, Patel NJ, Bhowmik T, D'Souza B, Akalkotkar A, Etzlar F, Oettinger CW, D'Souza M. Enhanced bioavailability of orally administered antisense oligonucleotide to nuclear factor kappa B mRNA after microencapsulation with albumin. Journal of Drug Targeting. 21: 450-7. PMID 23480723 DOI: 10.3109/1061186X.2013.765440 |
0.771 |
|
| 2013 |
Bejugam NK, Gayakwad SG, Uddin AN, D'Souza MJ. Microencapsulation of protein into biodegradable matrix: a smart solution cross-linking technique. Journal of Microencapsulation. 30: 274-82. PMID 23098577 DOI: 10.3109/02652048.2012.720724 |
0.772 |
|
| 2013 |
Kolluru LP, Rizvi SA, D'Souza M, D'Souza MJ. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. Journal of Drug Targeting. 21: 77-86. PMID 23036042 DOI: 10.3109/1061186X.2012.729214 |
0.507 |
|
| 2013 |
Ubale RV, D'Souza MJ, Infield DT, McCarty NA, Zughaier SM. Formulation of meningococcal capsular polysaccharide vaccine-loaded microparticles with robust innate immune recognition. Journal of Microencapsulation. 30: 28-41. PMID 22657751 DOI: 10.3109/02652048.2012.692402 |
0.337 |
|
| 2012 |
Chablani L, Tawde SA, Akalkotkar A, D'Souza C, Selvaraj P, D'Souza MJ. Formulation and evaluation of a particulate oral breast cancer vaccine. Journal of Pharmaceutical Sciences. 101: 3661-71. PMID 22828873 DOI: 10.1002/Jps.23275 |
0.339 |
|
| 2012 |
Tawde SA, Chablani L, Akalkotkar A, D'Souza C, Chiriva-Internati M, Selvaraj P, D'Souza MJ. Formulation and evaluation of oral microparticulate ovarian cancer vaccines. Vaccine. 30: 5675-81. PMID 22750042 DOI: 10.1016/J.Vaccine.2012.05.073 |
0.341 |
|
| 2012 |
Shastri PN, Kim MC, Quan FS, D'Souza MJ, Kang SM. Immunogenicity and protection of oral influenza vaccines formulated into microparticles. Journal of Pharmaceutical Sciences. 101: 3623-35. PMID 22711602 DOI: 10.1002/Jps.23220 |
0.303 |
|
| 2012 |
Oettinger CW, D'Souza MJ. Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition. Journal of Microencapsulation. 29: 455-62. PMID 22348221 DOI: 10.3109/02652048.2012.658443 |
0.364 |
|
| 2012 |
Bhowmik T, D'Souza B, Uddin MN, D'Souza MJ. Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen. Journal of Drug Targeting. 20: 364-71. PMID 22339323 DOI: 10.3109/1061186X.2012.662686 |
0.726 |
|
| 2012 |
Chablani L, Tawde SA, D'Souza MJ. Spray-dried microparticles: a potential vehicle for oral delivery of vaccines. Journal of Microencapsulation. 29: 388-97. PMID 22283700 DOI: 10.3109/02652048.2011.651503 |
0.403 |
|
| 2012 |
D'Souza B, Bhowmik T, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza M. Oral microparticulate vaccine for melanoma using M-cell targeting. Journal of Drug Targeting. 20: 166-73. PMID 21981679 DOI: 10.3109/1061186X.2011.622395 |
0.653 |
|
| 2011 |
Uddin MN, Siddiq A, Oettinger CW, D'Souza MJ. Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis. Journal of Drug Targeting. 19: 752-60. PMID 21913870 DOI: 10.3109/1061186X.2011.561856 |
0.562 |
|
| 2011 |
Lee KN, Ye Y, Carr JH, Karem K, D'Souza MJ. Formulation, pharmacokinetics and biodistribution of Ofloxacin-loaded albumin microparticles and nanoparticles. Journal of Microencapsulation. 28: 363-9. PMID 21736521 DOI: 10.3109/02652048.2011.569766 |
0.532 |
|
| 2011 |
Bhowmik T, D'Souza B, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza MJ. A novel microparticulate vaccine for melanoma cancer using transdermal delivery. Journal of Microencapsulation. 28: 294-300. PMID 21545320 DOI: 10.3109/02652048.2011.559287 |
0.617 |
|
| 2011 |
Jones AK, Bejugam NK, Nettey H, Addo R, D'Souza MJ. Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas. Journal of Drug Targeting. 19: 427-33. PMID 20678033 DOI: 10.3109/1061186X.2010.504270 |
0.801 |
|
| 2010 |
Oettinger CW, D'Souza MJ. Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-kappaB. Journal of Microencapsulation. 27: 372-6. PMID 20515262 DOI: 10.3109/02652040903243437 |
0.355 |
|
| 2010 |
Hwa Lai Y, D'Souza MJ. Labeling of Fluorescent Probes to Albumin Microspheres and B16 Melanoma Extra-Cellular Antigen. Current Drug Delivery. 7: 188-93. PMID 20497106 DOI: 10.2174/156720110791560982 |
0.303 |
|
| 2010 |
Akande J, Yeboah KG, Addo RT, Siddig A, Oettinger CW, D'Souza MJ. Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches. Journal of Microencapsulation. 27: 325-36. PMID 20055749 DOI: 10.3109/02652040903191834 |
0.791 |
|
| 2010 |
Addo RT, Siddig A, Siwale R, Patel NJ, Akande J, Uddin AN, D'Souza MJ. Formulation, characterization and testing of tetracaine hydrochloride-loaded albumin-chitosan microparticles for ocular drug delivery. Journal of Microencapsulation. 27: 95-104. PMID 20055748 DOI: 10.3109/02652040903010638 |
0.789 |
|
| 2010 |
Do DP, Pai SB, Rizvi SA, D'Souza MJ. Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. International Journal of Pharmaceutics. 386: 114-21. PMID 19922783 DOI: 10.1016/J.Ijpharm.2009.11.009 |
0.728 |
|
| 2010 |
Lai YH, D'Souza MJ. Labeling of fluorescent probes to albumin microspheres and B16 melanoma extra-cellular antigen Current Drug Delivery. 7: 188-193. DOI: 10.2174/156720110791560982 |
0.501 |
|
| 2009 |
Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D'Souza MJ. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. Journal of Microencapsulation. 26: 692-700. PMID 19888878 DOI: 10.3109/02652040802666910 |
0.805 |
|
| 2009 |
Siwale RC, Yeboah GK, Addo R, Oettinger CW, D'Souza MJ. The effect of intracellular antioxidant delivery (catalase) on hydrogen peroxide and proinflammatory cytokine synthesis: a new therapeutic horizon. Journal of Drug Targeting. 17: 710-8. PMID 19845487 DOI: 10.3109/10611860903161328 |
0.759 |
|
| 2009 |
Siwale RC, Oettinger CW, Addo R, Siddig A, D'Souza MJ. The effect of intracellular delivery of catalase and antisense oligonucleotides to NF-kappaB using albumin microcapsules in the endotoxic shock model. Journal of Drug Targeting. 17: 701-9. PMID 19845486 DOI: 10.3109/10611860903062070 |
0.778 |
|
| 2009 |
Angra PK, Siddig A, Nettey H, Desai N, Oettinger C, D'Souza MJ. Pharmacokinetic and biodistribution studies of amphotericin B microspheres. Journal of Microencapsulation. 26: 627-34. PMID 19839798 DOI: 10.3109/02652040802587173 |
0.796 |
|
| 2009 |
Angra PK, Oettinger C, Balakrishna Pai S, D'Souza MJ. Amphotericin B microspheres: a therapeutic approach to minimize toxicity while maintaining antifungal efficacy. Journal of Microencapsulation. 26: 580-7. PMID 19839793 DOI: 10.3109/02652040902797516 |
0.826 |
|
| 2009 |
Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D'Souza MJ. Oral delivery of gastro-resistant microencapsulated typhoid vaccine. Journal of Drug Targeting. 17: 553-60. PMID 19563303 DOI: 10.1080/10611860903067301 |
0.776 |
|
| 2009 |
Uddin MN, Do DP, Pai SB, Gayakwad S, Oettinger CW, D'Souza MJ. A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. The Analyst. 134: 1483-9. PMID 19562219 DOI: 10.1039/B823554F |
0.784 |
|
| 2009 |
Bumgarner GW, Shashidharamurthy R, Nagarajan S, D'Souza MJ, Selvaraj P. Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 137: 90-7. PMID 19328830 DOI: 10.1016/J.Jconrel.2009.03.011 |
0.793 |
|
| 2009 |
Lanke SS, Gayakwad SG, Strom JG, D'souza MJ. Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system. Journal of Microencapsulation. 26: 493-500. PMID 18846463 DOI: 10.1080/02652040802465719 |
0.793 |
|
| 2009 |
Siwale RC, Oettinger CW, Pai SB, Addo R, Uddin N, Siddig A, D'Souza MJ. Formulation and characterization of catalase in albumin microspheres. Journal of Microencapsulation. 26: 411-9. PMID 18821261 DOI: 10.1080/02652040802420409 |
0.812 |
|
| 2009 |
Akhavein N, Oettinger CW, Gayakwad SG, Addo RT, Bejugam NK, Bauer JD, Do D, Pollock SH, D'souza MJ. Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides. Journal of Microencapsulation. 26: 223-34. PMID 18666015 DOI: 10.1080/02652040802268691 |
0.753 |
|
| 2009 |
Yeboah KG, D'souza MJ. Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines. Journal of Microencapsulation. 26: 166-79. PMID 18608796 DOI: 10.1080/02652040802211717 |
0.367 |
|
| 2008 |
Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ. Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. Journal of Microencapsulation. 25: 577-83. PMID 19003560 DOI: 10.1080/02652040802476187 |
0.775 |
|
| 2008 |
Lai YH, D'Souza MJ. Microparticle transport in the human intestinal M cell model. Journal of Drug Targeting. 16: 36-42. PMID 18172818 DOI: 10.1080/10611860701639848 |
0.555 |
|
| 2008 |
Bejugam NK, Sou M, Uddin AN, Gayakwad SG, D'Souza MJ. Effect of chitosans and other excipients on the permeation of ketotifen, FITC-Dextran, and rhodamine 123 through caco-2 cells Journal of Bioactive and Compatible Polymers. 23: 187-202. DOI: 10.1177/0883911507088399 |
0.772 |
|
| 2007 |
Zhaowei J, D'Souza MJ, Oettinger CW. Reversal of LPS induced endothelial cell TNF synthesis and increased permeability with microencapsulated antisense oligomers to NF-kappaB. Journal of Microencapsulation. 24: 596-607. PMID 17654178 DOI: 10.1080/02652040701453477 |
0.324 |
|
| 2007 |
Oettinger CW, D'souza MJ, Akhavein N, Peer GT, Taylor FB, Kinasewitz GT. Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense oligomers to NF-kappaB. Journal of Microencapsulation. 24: 337-48. PMID 17497387 DOI: 10.1080/02652040601162525 |
0.79 |
|
| 2007 |
Lai YH, D'Souza MJ. Formulation and evaluation of an oral melanoma vaccine. Journal of Microencapsulation. 24: 235-52. PMID 17454435 DOI: 10.1080/02652040601162608 |
0.59 |
|
| 2007 |
Haswani DK, Nettey H, D'Souza MJ, Oettinger CW. In vitro evaluation and targeting of E. coli internalized by endothelial cells using albumin microspheres loaded with gentamicin. Drug Development and Industrial Pharmacy. 33: 181-90. PMID 17454050 DOI: 10.1080/03639040600865249 |
0.785 |
|
| 2007 |
Nettey H, Haswani D, D'Souza M, Oettinger C. In vitro antimicrobial effect of encapsulated vancomycin on internalized Staphylococcus aureus within endothelial cells. Drug Development and Industrial Pharmacy. 33: 133-9. PMID 17454044 DOI: 10.1080/03639040600867989 |
0.775 |
|
| 2006 |
Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. Journal of Microencapsulation. 23: 875-86. PMID 17390629 DOI: 10.1080/02652040601035093 |
0.822 |
|
| 2006 |
Nettey H, Haswani D, Oettinger CW, D'Souza MJ. Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. Journal of Microencapsulation. 23: 632-42. PMID 17118879 DOI: 10.1080/02652040600776564 |
0.821 |
|
| 2005 |
Bumgarner GW, Zampell JC, Nagarajan S, Poloso NJ, Dorn AS, D'Souza MJ, Selvaraj P. Modified cell ELISA to determine the solubilization of cell surface proteins: Applications in GPI-anchored protein purification. Journal of Biochemical and Biophysical Methods. 64: 99-109. PMID 16000225 DOI: 10.1016/J.Jbbm.2005.05.007 |
0.765 |
|
| 2005 |
D'Souza MJ, Jin Z, Oettinger CW. Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-kappaB. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 25: 311-20. PMID 15957954 DOI: 10.1089/Jir.2005.25.311 |
0.592 |
|
| 2004 |
Green MD, D'Souza MJ, Holbrook JM, Wirtz RA. In vitro and in vivo evaluation of albumin-encapsulated primaquine diphosphate prepared by nebulization into heated oil. Journal of Microencapsulation. 21: 433-44. PMID 15513749 DOI: 10.1080/02652040410001729232 |
0.367 |
|
| 2004 |
Oettinger C, D'Souza M. Microencapsulation of tumor necrosis factor oligomers: a new approach to proinflammatory cytokine inhibition. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 23: 533-43. PMID 14565862 DOI: 10.1089/10799900360708650 |
0.351 |
|
| 2003 |
Tong W, Wang L, D'Souza MJ. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin. Drug Development and Industrial Pharmacy. 29: 745-56. PMID 12906332 DOI: 10.1081/Ddc-120021774 |
0.616 |
|
| 2000 |
D'Souza M, Oettinger CW, Milton GV. Microspheres containing neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 beta protect rats from Staphylococcus aureus-induced peritonitis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 20: 907-13. PMID 11054279 DOI: 10.1089/10799900050163280 |
0.303 |
|
| 1999 |
D'souza MJ, Oettinger CW, Milton GV, Tracey KJ. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493 Journal of Interferon and Cytokine Research. 19: 1125-1133. PMID 10547152 DOI: 10.1089/107999099313064 |
0.352 |
|
| 1999 |
Shah AU, D'Souza MJ. Sustained-release interleukin-12 microspheres in the treatment of cancer Drug Development and Industrial Pharmacy. 25: 995-1004. PMID 10518239 DOI: 10.1081/Ddc-100102262 |
0.347 |
|
| 1999 |
D'Souza MJ, Oettinger CW, Shah A, Tipping PG, Huang XR, Milton GV. Macrophage depletion by albumin microencapsulated clodronate: Attenuation of cytokine release in macrophage-dependent glomerulonephritis Drug Development and Industrial Pharmacy. 25: 591-596. PMID 10219527 DOI: 10.1081/Ddc-100102213 |
0.313 |
|
| 1999 |
Oettinger CW, D'Souza M, Milton GV. Targeting macrophages with microspheres containing cytokine-neutralizing antibodies prevents lethality in gram-negative peritonitis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 19: 33-40. PMID 10048766 DOI: 10.1089/107999099314397 |
0.323 |
|
| 1998 |
D'Souza M, DeSouza P. Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats Drug Development and Industrial Pharmacy. 24: 841-852. PMID 9876535 DOI: 10.3109/03639049809088529 |
0.419 |
|
| 1996 |
Oettinger CW, D'Souza M, Milton GV. In vitro comparison of cytokine release from antithymocyte serum and OKT3: Inhibition with soluble and microencapsulated neutralizing antibodies Transplantation. 62: 1690-1693. PMID 8970633 DOI: 10.1097/00007890-199612150-00031 |
0.345 |
|
| 1995 |
D'Souza MJ, DeSouza P. Site specific microencapsulated drug targeting strategies- liver and gastro-intestinal tract targeting Advanced Drug Delivery Reviews. 17: 247-254. DOI: 10.1016/0169-409X(95)00058-F |
0.352 |
|
| 1988 |
D'Souza MJ. Controlled release of cyclosporine from microspheres Drug Development and Industrial Pharmacy. 14: 1351-1357. DOI: 10.3109/03639048809151937 |
0.387 |
|
| Show low-probability matches. |